dc.contributorLebedeva, I. V.
dc.contributorKovacs L.
dc.contributorCabral González Pablo, Universidad de la República (Uruguay). Facultad de Ciencias. Centro de Investigaciones Nucleares
dc.contributorChammas R.
dc.creatorKovacs, L.
dc.creatorCabral González, Pablo
dc.creatorChammas, R.
dc.date.accessioned2022-06-01T13:39:26Z
dc.date.accessioned2022-10-28T20:22:35Z
dc.date.available2022-06-01T13:39:26Z
dc.date.available2022-10-28T20:22:35Z
dc.date.created2022-06-01T13:39:26Z
dc.date.issued2020
dc.identifierKovacs, L, Cabral González, P y Chammas, R. "Mannose receptor 1 expression does not determine the uptake of high-density mannose dendrimers by activated macrophages populations". PLoS ONE. [en línea] 2020, 15(10): e0240455. 16 h. DOI: 10.1371/journal.pone.0240455
dc.identifier1932-6203
dc.identifierhttps://hdl.handle.net/20.500.12008/31778
dc.identifier10.1371/journal.pone.0240455
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4985583
dc.description.abstractThe presence of a high number of macrophages within solid tumors is often significantly associated with poor prognosis and predict treatment failure for chemotherapy and radiotherapy. Macrophages are innate immune cells capable of performing diverse functions depending on the different signals from the microenvironment. The classically activated macrophage is commonly present during the early stages of tumor development while alternatively activated macrophages are associated with more advanced tumors. The distinction of the antitumoral macrophages from the pro-tumoral macrophages is not absolute. However, they have different cell surface markers such as mannose receptor (MRC1 or CD206) abundantly expressed by macrophages treated with interleukin-4 (IL-4). The important roles of macrophages in cancers suggest that it is important to develop novel therapies that target these cells. In the present study, we designed a probe using Polyamidoamine (PAMAM) fifth-generation (G5) dendrimers conjugated with mannose, Cyanine 7 (Cy7), and hydrazinonicotinamide (HYNIC) for target macrophages with high expression of MRC1 in the tumor. The intracellular uptake of 99mTc-HYNIC-dendrimer-mannose-Cy7 through the interaction with MRC1 in bone marrow-derived macrophages (BMDMs) untreated or treated with lipopolysaccharides (LPS) + interferon (IFN)γ or IL-4 was analyzed. Our results show that high-density mannose dendrimers are preferentially bound by macrophages treated by IFNγ and LPS that express lower levels of MRC1 than for macrophages treated by IL-4 that express high levels of MRC1. Furthermore, the intracellular 99mTc-HYNIC-dendrimer-mannose-Cy7 uptake in BMDMs was not inhibited in the presence of free mannose or glucose. This result suggests that 99mTc-HYNIC-dendrimer-mannose-Cy7 is not internalized via macrophage MRC1. Based on these findings, we concluded that MRC1 expression does not determine the uptake of high-density mannose dendrimers.
dc.languageen
dc.publisherPublic Library of Science
dc.relationPLoS ONE, 2020, 15(10): e0240455
dc.rightsLicencia Creative Commons Atribución (CC - By 4.0)
dc.rightsLas obras depositadas en el Repositorio se rigen por la Ordenanza de los Derechos de la Propiedad Intelectual de la Universidad de la República.(Res. Nº 91 de C.D.C. de 8/III/1994 – D.O. 7/IV/1994) y por la Ordenanza del Repositorio Abierto de la Universidad de la República (Res. Nº 16 de C.D.C. de 07/10/2014)
dc.subjectMacrophages
dc.subjectRadiopharmaceuticals
dc.subjectMannose dendrimers
dc.subjectImmunologic receptors
dc.subject99mTc-HYNIC-dendrimer-mannose-Cy7
dc.titleMannose receptor 1 expression does not determine the uptake of high-density mannose dendrimers by activated macrophages populations
dc.typeArtículo


Este ítem pertenece a la siguiente institución